Skip to content

Comparative Efficacy of Psilocybin and MDMA in PTSD Treatment: A Systematic Review of Long-Term Outcomes

Presley Aspen

Berkeley Scientific Journal November 13, 2025 DOI: 10.5070/bs329265627 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Review Peer reviewed
Topics MDMA Psilocybin PTSD
Keywords Hallucinogen
Key findings The review compares psilocybin and MDMA's effectiveness in treating PTSD.

Abstract

Highly stressful events can lead to post-traumatic stress disorder (PTSD)-a significant public health concern which existing treatments (e.g., psychotherapy and traditional medications) have shown marginal efficacy for.Psychedelics-alternatively called hallucinogens-are psychoactive substances that cause perception, mood, and cognitive changes.Because they are known for their impact on neuron plasticity and the formation of new connections, researchers are exploring psychedelics' therapeutic potential for PTSD.This review compares psilocybin and MDMA's effectiveness in treating PTSD.

In the evidence

This study is part of the evidence base for a synthesis in the library. Here is how each one recorded it.

Comparable studies

Other narrative reviews on psilocybin for PTSD, most cited first.

Explore topics

By condition and practice